{{Rsnum
|rsid=1227969
|Gene=TSPAN15
|Chromosome=10
|position=71263264
|Orientation=minus
|GMAF=0.3315
|Gene_s=TSPAN15
|Assembly=GRCh37.p5
|GenomeBuild=37.3
|dbSNPBuild=137
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 16.8 | 46.9 | 36.3
| HCB | 0.7 | 26.3 | 73.0
| JPT | 2.7 | 20.4 | 77.0
| YRI | 27.9 | 51.0 | 21.1
| ASW | 19.3 | 59.6 | 21.1
| CHB | 0.7 | 26.3 | 73.0
| CHD | 0.9 | 22.9 | 76.1
| GIH | 13.9 | 42.6 | 43.6
| LWK | 33.6 | 50.9 | 15.5
| MEX | 6.9 | 39.7 | 53.4
| MKK | 25.6 | 50.0 | 24.4
| TSI | 9.8 | 46.1 | 44.1
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23006423
  |Trait=Response to taxane treatment (placlitaxel)
  |Title=Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.
  |RiskAllele=
  |Pval=6E-7
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | Affy GenomeWide 6}}